"SIFI#39;s innovative IOLs (Intraocular lenses) have been approved by the Indian Central Drugs Standards Control Organisation (Directorate General of Health Services) and Ministry of Health Family Welfare (Medical Device and Diagnostic Division)," Zydus Cadila said in a regulatory filing.
How to protect and exponentially Grow your investment portfolio during economic boom or bust, How learn stock market, How to earn money in stock market,earn money from home .
Subscribe to:
Post Comments (Atom)
-
Huawei faces international scrutiny over its ties with the Chinese government and suspicion that Beijing could use Huawei#39;s technology f...
-
In July, HCL Technologies had announced a Rs 4,000 crore buyback programme for FY19 at a price of Rs 1,100 per equity share.
No comments:
Post a Comment